TomegaVax's Acquisition

TomegaVax was acquired by Vir Biotechnology on January 25, 2017.

TomegaVax develops vaccines and immunotherapies for chronic and recurring viral infections. The company was founded in 2011 and is based in Beaverton, Oregon.…

Articles about TomegaVax's Acquisition: